Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
Completed
Conditions studied: Brain and Central Nervous System Tumors, Lymphoma
In brief
RATIONALE: Determination of genetic markers for leukemia or non-Hodgkin's lymphoma that is secondary to Hodgkin's disease and childhood brain tumors may help doctors to identify patients who are at risk for these cancers. PURPOSE: Clinical trial to determine the presence of certain genes in patients who are receiving treatment for Hodgkin's disease or childhood brain tumors.
Key facts
- Study ID
- NCT00006342
- Run by
- Duke University
- People needed
- 19
- Starts
- 1997-01-01
- Expected to finish
- 2001-01-01
- Last updated by the study team
- 2015-10-15
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.